Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Terminated2
Other2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06110715Not ApplicableWithdrawn
Quantifying tACS-driven Improvement of Working Memory in Depression
Depression
PrincipalinvestigatorStart date: 2023-09-05
NCT04426214Not ApplicableTerminated
Neuromodulation and Cognitive Training for Substance Use Disorders
Alcohol Use DisorderStimulant Use
PrincipalinvestigatorStart date: 2021-07-16
NCT04495673Not ApplicableTerminated
Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder
Heroin DependenceMorphine DependenceOpioid-Related Disorders
PrincipalinvestigatorStart date: 2021-01-11
NCT06695637Early Phase 1Withdrawn
Individualized Neuromodulation of Craving Control for Meth Use Disorders
Methamphetamine Use DisordersSubstance Use Disorders
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jazmin Camchong, PhD

University of Minnesota

Moderately Similar
6 trials

Shared therapeutic areas:

Alcohol Use DisorderHeroin DependenceMorphine Dependence+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)University of Minnesota
Collaborated on 1 trial
Similarity Score44%

Alexander Opitz, PhD

University of Minnesota

Related
3 trials

Shared therapeutic areas:

Depression

Worked with same sponsors:

University of Minnesota
Collaborated on 1 trial
Similarity Score14%

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

DepressionOpioid-Related DisordersSubstance Use Disorders
Similarity Score11%

Madhukar Trivedi, MD

University of Texas Southwestern Medical Center

Related
13 trials

Shared therapeutic areas:

DepressionSubstance Use Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score8%

Heather Hadjistavropoulos, PhD

University of Regina

Related
15 trials

Shared therapeutic areas:

DepressionAlcohol Use Disorder
Similarity Score8%

Walter Ling, M.D.

Friends Research Institute, Inc.

Related
28 trials

Shared therapeutic areas:

Opioid-Related DisordersHeroin Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score8%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score8%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

DepressionAlcohol Use Disorder
Similarity Score8%

Gerhard Andersson, Professor

Linkoeping University

Related
12 trials

Shared therapeutic areas:

DepressionAlcohol Use Disorder
Similarity Score8%

Anne H Berman, PhD

Karolinska Institutet

Related
14 trials

Shared therapeutic areas:

Alcohol Use DisorderSubstance Use Disorders
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06110715Not ApplicablePrincipalInvestigator

Quantifying tACS-driven Improvement of Working Memory in Depression

Depression
Withdrawn
NCT04426214Not ApplicablePrincipalInvestigator

Neuromodulation and Cognitive Training for Substance Use Disorders

Alcohol Use DisorderStimulant Use
Terminated
NCT04495673Not ApplicablePrincipalInvestigator

Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder

Heroin DependenceMorphine DependenceOpioid-Related Disorders
Terminated
NCT06695637Early Phase 1PrincipalInvestigator

Individualized Neuromodulation of Craving Control for Meth Use Disorders

Methamphetamine Use DisordersSubstance Use Disorders
Withdrawn

All 4 trials loaded